Interventions for non-metastatic squamous cell carcinoma of the skin

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 3, 2010, Pages

  Lansbury, Louise ^a   Leonardi Bee, Jo ^a   Perkins, William ^b   Goodacre, Timothy ^c   Tweed, John A ^a   Bath Hextall, Fiona J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; HUMAN; PATHOLOGY; REVIEW; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; CARCINOMA, SQUAMOUS CELL; HUMANS; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 77952489416     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007869.pub2     Document Type: Review

References (74)

1. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, et al. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2007;25(15):1974-8.
2. Brandt MG, Moore CC, Jordan K. Randomized control trial of fluorescence-guided surgical excision of nonmelanotic cutaneous malignancies. The Journal of Otolaryngology 2007;36(3):148-55.
3. Cham BE, Daunter B, Evans RA. Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. Cancer Letters 1991;59(3):183-92.
4. Coates AS, Tattersall MH, Swanson C, Hedley D, Fox RM, Raghavan D. Combination therapy with methotrexate and 5-fluorouracil: A prospective randomized clinical trial of order of administration. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 1984;2(7):756-61.
5. Eedy D. Immunomodulators in the treatment of skin cancer. Abstract S37-6. The 12th Congress of the European Academy of Dermatology and Venereology. Barcelona, Spain 15-18th October 2003. Journal of the European Academy of Dermatology and Venereology 2003;17(Suppl 3):49.
6. Haas CD. Phase II evaluation of bleomycin. A Southwest oncology Group study. Cancer 1976;38(1):8-12.
7. Healy JB. The use of topical 5-fluorouracil in the treatment of skin tumours - Preliminary report. Journal of the Irish Medical Association 1969;62(380):41-6.
8. Landthaler M, Braun-Falco O. TDF factors in soft x-ray therapy [Anwendung des TDF-Faktors in der Röntgenweichstrahlentherapie]. Hautarzt 1989;40:774-777.
9. Lui H, Hobbs L, Tope WD, Lee PK, Elmets C, Provost N, et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: Two-year results evaluating tumor response and cosmetic outcomes. Archives of Dermatology 2004;140(1):26-32.
10. Moseley HS, Sasaki T, McConnell DB, Merhoff GC, Wilson WL, Grage TB, et al. A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma. Journal of Surgical Oncology 1976;8(1):35-42.
11. Medical Research Council Working party on Bleomycin. Bleomycin in advanced squamous cell carcinoma: a random controlled trial. Report of Medical Research Council Working Party on Bleomycin. British Medical Journal 1976;1(6003):188-90.
12. Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. American Journal of Clinical Oncology 1991;14(2):133-141.
13. Radny P, Garbe C, Bruckner-Tuderman L, Nashan D. Selective Electrochemical Tumour Ablation (SECTA) with Intralesional Bleomycin Abstract 6. 3rd meeting of the European Association of Dermato-Oncology, Rome 23-25 June 2006. Journal of Investigative Dermatology 2006;126(Suppl 2):S2.
14. Seyss R. On the practice of soft ray and proximity radiotherapy in skin and lip carcinomas [Zur Praxis der Weichstrahl- und Nahbestrahlungstherapie bei Haut- und Lippenkarzinomen]. Wiener Medizinische Wochenschrift 1968;118(2):34-6.
15. Post-operative concurrent chemo-radiotherapy (Carboplatin) versus post-operative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck to improve loco-regional relapse. Ongoing study 20/4/05.
16. Alam M, Ratner D. Primary care: Cutaneous squamous-cell carcinoma. New England Journal of Medicine 2001;344(13):975-983.
17. Albrecht J, Bigby M. What makes a good case series?. In: Williams H, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B editor(s). Evidence-Based Dermatology. Second Edition. Blackwell Publishing, 2008:56-60.
18. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
19. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. Journal of Photochemistry and Photobiology B:Biology 2001;63(1-3):8-18.
20. Auerbach H. Geographic variation in incidence of skin cancer in the United States. Public Health Reports 1961;76(4):345-8.
21. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858]
22. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-1218.
23. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, Macnaught A, O'Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: A follow-up study. Transplantation 1996;61(5):715-721.
24. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville Australia. International Journal of Cancer 1998;78(5):587-93.
25. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatologic Surgery 2002;28:268-73.
26. De Hertog SAE, Wensveen CA, Bastiaens MT, Kielich CJ, Berkhout MJP, Westendorp RGJ. Relation between smoking and skin cancer. Journal of Clinical Oncology 2001;19(1):231-8.
27. Demopoulos BP, Vamvakas E, Ehrlich JE, Demopoulos R. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Archives of Pathology and Laboratory Medicine 2003;127(5):589-92.
28. Diepgen TL, Mahler V. The epidemiology of skin cancer. British Journal of Dermatology 2002;146(Suppl 61):1-6.
29. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. Journal of the American Academy of Dermatology 1989;21:241-8.
30. Fine JD, Johnson LB, Suchidran C, Bauer EA, Carter DM, McGuire J. Cancer and inherited epidermolysis bullosa: Lifetable analyses of the National Epidermolysis Bullosa Registry study population. In: Fine JD, Bauer EA, McGuire J, Moshell A editor(s). Epidermolysis bullosa: Clinical, epidemiologic, and laboratory advances, and the findings of the national epidermolysis bullosa registry. Baltimore: John Hopkins University Press, 1999:175-192.
31. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer:II. Squamous cell carcinoma. Archives of Dermatology 1995;131:164-9.
32. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. Journal of the American Medical Association 1989;262(15):2097-100.
33. Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatologic Surgery 1996;22(3):217-26.
34. Gloster HM, Neal K. Skin cancer in skin of color. Journal of the American Academy of Dermatology 2006;55(5):741-760.
35. Department of Health. The New NHS: modern, dependable. London. The Stationery Office Ltd 1997:Clause 1.13.
36. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a sub-tropical Australian population: Incidence and lack of association with occupation. American Journal of Epidemiology 1996;144(11):1034-40.
37. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995;75(2):667-73.
38. Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980;87(2):177-83.
39. Hartevelt MM, Bouwes Bavinck JN, Kootte AM, Vermeer BI, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49(3):506-9.
40. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Current Opinion in Infectious Diseases 2002;15(2):101-114.
41. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org 2008.
42. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales 1988-98. British Journal of Dermatology 2000;143(6):1224-9.
43. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. Journal of the American Academy of Dermatology 1999;40:177-86.
44. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). Journal of the American Academy of Dermatology 1992;26(3):467-84.
45. Kao GF. Carcinoma arising in Bowen's disease. Archives of Dermatology 1986;122(10):1124-6.
46. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, et al. Human papillovirus infection and incidence of squamous cell and basal cell carcinomas of the skin. Journal of the National Cancer Institiute 2006;98(6):389-395.
47. Karagas MR, Nelson HH, Zens MS, Linet M, Stukel TA, Spencer S, et al. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007;18(6):776-84.
48. Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet light-treated psoriasis patients. Journal of Investigative Dermatology 2002;118(6):1038-43.
49. Leong GK, Stone JL, Farmer ER, Scotto J, Reizner GT, Burnett TS, et al. Nonmelanoma skin cancer in Japanese residents of Kauai, Hawaii. Journal of the American Academy of Dermatology 1987;17:233-8.
50. Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. Journal of Investigative Dermatology 2005;124(3):505-13.
51. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JPA. Risk of neoplasia in renal transplant patients. The Lancet 1995;346:403-06.
52. Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: The case for conservative management. British Journal of Dermatology 1986;115(6):649-55.
53. Marks R. Squamous cell carcinoma. Lancet 1996;347(9003):735-8.
54. May GS, Demets DL, Friedman LM, Furberg C, Passamani E. The randomized clinical trial: Bias in analysis. Circulation 1981;64:669-73.
55. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. Journal of the American Academy of Dermatology 1994;30(5):774-80.
56. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. British Journal of Dermatology 2006;154:498-504.
57. Mora RG, Perniciaro C. Cancer of the skin in blacks.I. A review of 163 black people with cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 1981;5(5):535-43.
58. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Journal of Dermatology 146;1:18-25.
59. Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000;70(10):1479-1484.
60. Nijsten TEC, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: A cohort study. Journal of Investigative Dermatology 2003;121(2):252-8.
61. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
62. Pennello G, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiology Biomarkers and Prevention 2000;9:291-7.
63. Peterka ES, Lynch FW, Goltz RW. An association between Bowen's Disease and internal cancer. Archives of Dermatology 1961;84:623-9.
64. Preston DS, Stern RS. Nonmelanoma cancers of the skin. New England Journal of Medicine 1992;327(23):1649-62.
65. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Nicol DL, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. British Journal of Dermatology 2002;147:950-956.
66. Rowe DE, Carroll RJ, Day Jr CJ. Prognostic factors for local recurrence, metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip: Implications for treatment modality selection. Journal of the American Academy of Dermatology 1992;26:976-90.
67. Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. New England Journal of Medicine 1979;301:1410-12.
68. Schulz KF, Chalmers I, Hayes RJ. Empirical evidence of bias. Journal of the American Medical Academy 1995;273:408-12.
69. Scotto J, Fears TR, Fraumeni JF Jr. Incidence of nonmelanoma skin cancer in the United States. Washington (DC): U.S. Government Printing Office, 1981. National Cancer Institute, DHSS Report No. NIH 82-2433 1981.
70. Sober AJ. Diagnosis and management of skin cancer. Cancer 1983;51(12 Suppl):2448-52.
71. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: The 2002 national survey and trends since 1985. Medical Journal of Australia 2006;184(1):6-10.
72. Stranc MF, Fogel M, Dische S. Comparison of lip function: Surgery vs radiotherapy. British Journal of Plastic Surgery 1987;40(6):598-604.
73. Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Archives of Dermatology 1993;129:1286-90.
74. Yu H-S, Liao W-T, Chai C-Y. Arsenic carcinogenesis in the skin. Journal of Biomedical Science 2006;13(5):657-66.